ID   PSMD2_RAT               Reviewed;         908 AA.
AC   Q4FZT9;
DT   05-FEB-2008, integrated into UniProtKB/Swiss-Prot.
DT   30-AUG-2005, sequence version 1.
DT   02-OCT-2024, entry version 133.
DE   RecName: Full=26S proteasome non-ATPase regulatory subunit 2;
GN   Name=Psmd2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-361, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Component of the 26S proteasome, a multiprotein complex
CC       involved in the ATP-dependent degradation of ubiquitinated proteins.
CC       This complex plays a key role in the maintenance of protein homeostasis
CC       by removing misfolded or damaged proteins, which could impair cellular
CC       functions, and by removing proteins whose functions are no longer
CC       required. Therefore, the proteasome participates in numerous cellular
CC       processes, including cell cycle progression, apoptosis, or DNA damage
CC       repair. {ECO:0000250|UniProtKB:Q13200}.
CC   -!- FUNCTION: Binds to the intracellular domain of tumor necrosis factor
CC       type 1 receptor. The binding domain of TRAP1 and TRAP2 resides outside
CC       the death domain of TNFR1. {ECO:0000250|UniProtKB:Q13200}.
CC   -!- SUBUNIT: Component of the 19S proteasome regulatory particle complex.
CC       The 26S proteasome consists of a 20S core particle (CP) and two 19S
CC       regulatory subunits (RP). The regulatory particle is made of a lid
CC       composed of 9 subunits, a base containing 6 ATPases and few additional
CC       components including PSMD2 (By similarity). Interacts with RPGRIP1L (By
CC       similarity). Interacts with CRY1 in a KDM8-dependent manner (By
CC       similarity). Interacts (via C-terminus) with phosphatase UBLCP1 (via
CC       ubiquitin-like domain); the interaction recruits UBLCP1 to the 19S
CC       regulatory particle where it dephosphorylates 19S subunit PSMC2/RPT1
CC       which impairs PSMC2 ATPase activity and disrupts 26S proteasome
CC       assembly (By similarity). {ECO:0000250|UniProtKB:Q13200,
CC       ECO:0000250|UniProtKB:Q8VDM4}.
CC   -!- SIMILARITY: Belongs to the proteasome subunit S2 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC099135; AAH99135.1; -; mRNA.
DR   RefSeq; NP_001026809.1; NM_001031639.1.
DR   PDB; 6EPC; EM; 12.30 A; Z=1-908.
DR   PDB; 6EPD; EM; 15.40 A; Z=1-908.
DR   PDB; 6EPE; EM; 12.80 A; Z=1-908.
DR   PDB; 6EPF; EM; 11.80 A; Z=1-908.
DR   PDBsum; 6EPC; -.
DR   PDBsum; 6EPD; -.
DR   PDBsum; 6EPE; -.
DR   PDBsum; 6EPF; -.
DR   AlphaFoldDB; Q4FZT9; -.
DR   EMDB; EMD-3913; -.
DR   EMDB; EMD-3914; -.
DR   EMDB; EMD-3915; -.
DR   EMDB; EMD-3916; -.
DR   SMR; Q4FZT9; -.
DR   BioGRID; 252405; 9.
DR   ComplexPortal; CPX-8962; 19S proteasome regulatory complex.
DR   ComplexPortal; CPX-8965; 30S proteasome complex.
DR   IntAct; Q4FZT9; 7.
DR   MINT; Q4FZT9; -.
DR   STRING; 10116.ENSRNOP00000002358; -.
DR   iPTMnet; Q4FZT9; -.
DR   PhosphoSitePlus; Q4FZT9; -.
DR   jPOST; Q4FZT9; -.
DR   PaxDb; 10116-ENSRNOP00000002358; -.
DR   Ensembl; ENSRNOT00000002358.7; ENSRNOP00000002358.4; ENSRNOG00000001719.7.
DR   Ensembl; ENSRNOT00055007678; ENSRNOP00055005793; ENSRNOG00055004817.
DR   Ensembl; ENSRNOT00060020126; ENSRNOP00060015799; ENSRNOG00060011897.
DR   Ensembl; ENSRNOT00065005951; ENSRNOP00065004268; ENSRNOG00065004072.
DR   GeneID; 287984; -.
DR   KEGG; rno:287984; -.
DR   AGR; RGD:1305752; -.
DR   CTD; 5708; -.
DR   RGD; 1305752; Psmd2.
DR   eggNOG; KOG2005; Eukaryota.
DR   GeneTree; ENSGT00940000153386; -.
DR   HOGENOM; CLU_008705_1_0_1; -.
DR   InParanoid; Q4FZT9; -.
DR   OMA; GTCNGDI; -.
DR   OrthoDB; 1114323at2759; -.
DR   PhylomeDB; Q4FZT9; -.
DR   TreeFam; TF105739; -.
DR   Reactome; R-RNO-1169091; Activation of NF-kappaB in B cells.
DR   Reactome; R-RNO-1234176; Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha.
DR   Reactome; R-RNO-1236978; Cross-presentation of soluble exogenous antigens (endosomes).
DR   Reactome; R-RNO-174084; Autodegradation of Cdh1 by Cdh1:APC/C.
DR   Reactome; R-RNO-174113; SCF-beta-TrCP mediated degradation of Emi1.
DR   Reactome; R-RNO-174154; APC/C:Cdc20 mediated degradation of Securin.
DR   Reactome; R-RNO-174178; APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1.
DR   Reactome; R-RNO-174184; Cdc20:Phospho-APC/C mediated degradation of Cyclin A.
DR   Reactome; R-RNO-187577; SCF(Skp2)-mediated degradation of p27/p21.
DR   Reactome; R-RNO-195253; Degradation of beta-catenin by the destruction complex.
DR   Reactome; R-RNO-2467813; Separation of Sister Chromatids.
DR   Reactome; R-RNO-349425; Autodegradation of the E3 ubiquitin ligase COP1.
DR   Reactome; R-RNO-350562; Regulation of ornithine decarboxylase (ODC).
DR   Reactome; R-RNO-382556; ABC-family proteins mediated transport.
DR   Reactome; R-RNO-450408; AUF1 (hnRNP D0) binds and destabilizes mRNA.
DR   Reactome; R-RNO-4608870; Asymmetric localization of PCP proteins.
DR   Reactome; R-RNO-4641257; Degradation of AXIN.
DR   Reactome; R-RNO-4641258; Degradation of DVL.
DR   Reactome; R-RNO-5358346; Hedgehog ligand biogenesis.
DR   Reactome; R-RNO-5607761; Dectin-1 mediated noncanonical NF-kB signaling.
DR   Reactome; R-RNO-5610780; Degradation of GLI1 by the proteasome.
DR   Reactome; R-RNO-5610785; GLI3 is processed to GLI3R by the proteasome.
DR   Reactome; R-RNO-5632684; Hedgehog 'on' state.
DR   Reactome; R-RNO-5658442; Regulation of RAS by GAPs.
DR   Reactome; R-RNO-5668541; TNFR2 non-canonical NF-kB pathway.
DR   Reactome; R-RNO-5676590; NIK-->noncanonical NF-kB signaling.
DR   Reactome; R-RNO-5687128; MAPK6/MAPK4 signaling.
DR   Reactome; R-RNO-5689603; UCH proteinases.
DR   Reactome; R-RNO-5689880; Ub-specific processing proteases.
DR   Reactome; R-RNO-6798695; Neutrophil degranulation.
DR   Reactome; R-RNO-68867; Assembly of the pre-replicative complex.
DR   Reactome; R-RNO-68949; Orc1 removal from chromatin.
DR   Reactome; R-RNO-69017; CDK-mediated phosphorylation and removal of Cdc6.
DR   Reactome; R-RNO-69481; G2/M Checkpoints.
DR   Reactome; R-RNO-69601; Ubiquitin Mediated Degradation of Phosphorylated Cdc25A.
DR   Reactome; R-RNO-75815; Ubiquitin-dependent degradation of Cyclin D.
DR   Reactome; R-RNO-8852276; The role of GTSE1 in G2/M progression after G2 checkpoint.
DR   Reactome; R-RNO-8854050; FBXL7 down-regulates AURKA during mitotic entry and in early mitosis.
DR   Reactome; R-RNO-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-RNO-8941858; Regulation of RUNX3 expression and activity.
DR   Reactome; R-RNO-8948751; Regulation of PTEN stability and activity.
DR   Reactome; R-RNO-8951664; Neddylation.
DR   Reactome; R-RNO-9755511; KEAP1-NFE2L2 pathway.
DR   Reactome; R-RNO-9762114; GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2.
DR   Reactome; R-RNO-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   PRO; PR:Q4FZT9; -.
DR   Proteomes; UP000002494; Chromosome 11.
DR   Bgee; ENSRNOG00000001719; Expressed in skeletal muscle tissue and 19 other cell types or tissues.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0022624; C:proteasome accessory complex; ISS:UniProtKB.
DR   GO; GO:0000502; C:proteasome complex; ISO:RGD.
DR   GO; GO:0005838; C:proteasome regulatory particle; ISO:RGD.
DR   GO; GO:0008540; C:proteasome regulatory particle, base subcomplex; IBA:GO_Central.
DR   GO; GO:0034515; C:proteasome storage granule; IBA:GO_Central.
DR   GO; GO:0030234; F:enzyme regulator activity; IEA:InterPro.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0042176; P:regulation of protein catabolic process; IEA:InterPro.
DR   Gene3D; 1.25.10.10; Leucine-rich Repeat Variant; 1.
DR   InterPro; IPR016643; 26S_Psome_Rpn1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR002015; Proteasome/cyclosome_rpt.
DR   InterPro; IPR041433; RPN1_C.
DR   InterPro; IPR040892; RPN1_N.
DR   PANTHER; PTHR10943; 26S PROTEASOME NON-ATPASE REGULATORY SUBUNIT; 1.
DR   PANTHER; PTHR10943:SF1; 26S PROTEASOME NON-ATPASE REGULATORY SUBUNIT 2; 1.
DR   Pfam; PF01851; PC_rep; 2.
DR   Pfam; PF18051; RPN1_C; 1.
DR   Pfam; PF17781; RPN1_RPN2_N; 1.
DR   PIRSF; PIRSF015965; 26S_Psome_Rpn1; 1.
DR   SUPFAM; SSF48371; ARM repeat; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Phosphoprotein; Proteasome; Reference proteome;
KW   Repeat.
FT   CHAIN           1..908
FT                   /note="26S proteasome non-ATPase regulatory subunit 2"
FT                   /id="PRO_0000317028"
FT   REPEAT          409..442
FT                   /note="PC 1"
FT   REPEAT          443..479
FT                   /note="PC 2"
FT   REPEAT          480..514
FT                   /note="PC 3"
FT   REPEAT          517..551
FT                   /note="PC 4"
FT   REPEAT          560..589
FT                   /note="PC 5"
FT   REPEAT          692..723
FT                   /note="PC 6"
FT   REPEAT          742..757
FT                   /note="PC 7"
FT   REGION          1..51
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          623..645
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          708..903
FT                   /note="Required for interaction with UBLCP1"
FT                   /evidence="ECO:0000250|UniProtKB:Q13200"
FT   COMPBIAS        8..24
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        26..51
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDM4"
FT   MOD_RES         9
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDM4"
FT   MOD_RES         29
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13200"
FT   MOD_RES         147
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13200"
FT   MOD_RES         194
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13200"
FT   MOD_RES         361
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         363
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13200"
FT   MOD_RES         551
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDM4"
SQ   SEQUENCE   908 AA;  100188 MW;  FAB93C42A49E54FB CRC64;
     MEEGGRDKTP VQSQQPSATA PSGADEKSSG KERRDAGEKD KEQELSEEDK QLQDELEMLV
     ERLGEKDTSL YRPALEELRR QIRSSTTSMT SVPKPLKFLR PHYGKLKEIY ENMAPGENKC
     FAADIISVLA MTMSGERECL KYRLVGSQEE LASWGHEYVR HLAGEVAKEW QELDDAEKAQ
     REPLLTLVKE IVPYNMAHNA EHEACDLLME IEQVDMLEKD IDENAYSKVC LYLTSCVNYV
     PEPENSALLR CALGVFRKFS RFPEALRLAL MLNDMELVED IFTSCKDVVV QKQMAFMLGR
     HGVFLELSED VEEYEDLTEI MSNVQLNSNF LALARELDIM EPKVPDDIYK THLENNRFGG
     SGSQVDSARM NLASSFVNGF VNAAFGQDKL LTDDGNKWLY KNKDHGMLSA AASLGMILLW
     DVDGGLTQID KYLYSSEDYI KSGALLACGI VNSGVRNECD PALALLSDYV LHNSNTMRLG
     SIFGLGLAYA GSNREDVLTL LLPVMGDSKS SMEVAGVTAL ACGMIAVGSC NGDVTSTILQ
     TIMEKSETEL KDTYARWLPL GLGLNHLGKG EAIEAILAAL EVVSEPFRSF ANTLVDVCAY
     AGSGNVLKVQ QLLHICSEHF DSKEKEEDKD KKEKKDKDKK EAPADMGAHQ GVAVLGIALI
     AMGEEIGAEM ALRTFGHLLR YGEPTLRRAV PLALALISVS NPRLNILDTL SKFSHDADPE
     VSYNSIFAMG MVGSGTNNAR LAAMLRQLAQ YHAKDPNNLF MVRLAQGLTH LGKGTLTLCP
     YHSDRQLMSQ VAVAGLLTVL VSFLDVRNII LGKSHYVLYG LVAAMQPRML VTFDEELRPL
     PVSVRVGQAV DVVGQAGKPK TITGFQTHTT PVLLAHGERA ELATEEFLPV TPILEGFVIL
     RKNPNYNL
//
